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What is the system failure?
FL Delmonico1
As a result of the increasing use of live organ donors, international 
conferences have been held in Amsterdam and Vancouver to address 
the transplant community’s concern for the well-being of such donors. 
Congress has considered arguments to permit a regulated market 
of organ sales but has rejected such a proposal, in part because of a 
fundamental ethical principle: selling one’s kidney or any other part 
of one’s body violates the dignity of the human person. The “system 
failure” is not only at the doorstep of organ donation. The expansion of 
the waiting list for kidney transplants is heavily composed of the elderly 
who could have benefited by preventive medical care.
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Th e shortage of organs for transplantation 
is widely known and is aff ecting the prac-
tice of transplantation around the world. 
Th e demand for organs has propelled an 
international use of live organ donors 
that only a few years ago would have 
been considered an alarming develop-
ment by the World Health Organization, 
which, in a resolution in 1991, called for 
the preferential transplantation of organs 
from deceased donors.1 As a result of the 
increasing use of live donors, international 
conferences have been held in Amsterdam 
and Vancouver to address the transplant 
community’s concern for the well-being 
of such donors.2,3 Ethics statements have 
emphasized the necessity of informed 
consent and the proper care of an organ 
donor, whether the donation is altruis-
tic (without monetary compensation) 
or is as a vendor of an organ sale.4  (We 
should be clear that there is no interna-
tional objection to the reimbursement of 
donors’ expenses; it is the sole motivation 
of monetary gain that brings controversy.) 
In each of these conferences, however, 
the participants did not resolve the most 
contentious issue: the ethical propriety of 
buying and selling organs.
In “Payment for donor kidneys: pros 
and cons”5 (this issue), Drs. Eli and Amy 
Friedman present a perspective that, given 
the stature of the authors, necessitates 
commentary. Th e paper’s title cites “pros 
and cons”; however, its content is clearly 
weighted toward an advocacy for the gov-
ernment to pay vendors for their kidneys.
Several years ago, I had the honor to 
debate Dr. Eli Friedman (in his home terri-
tory in Brooklyn, New York) regarding the 
use of monetary compensation for organs. 
As Dr. Friedman has been widely known 
as a proponent of organ sales, the debate 
off ered an anticipated exchange of opinion, 
with my presenting an opposing view. Th e 
arguments that Dr. Friedman made in that 
debate years ago and those used in the cur-
rent refl ection in Kidney International are 
the same; there is nothing new. So why has 
the United States Congress not adopted 
the recommendations of the Friedmans to 
“establish a federal agency to manage the 
marketing and purchase of donor kidneys 
in collaboration with the United Network 
for Organ Sharing”?
As the current president of the United 
Network for Organ Sharing (UNOS), 
permit me to make clear that there is 
no resolution before the UNOS Board 
of Trustees to consider such a proposal 
— nor will there be a recommendation 
to do so. Second, also perhaps to the 
authors’ dismay, Congress did not accept 
those debate arguments made years ago 
by Dr. E. Friedman, in the draft ing of the 
2004 legislation by Senator William Frist. 
Unequivocally, Congress rejected them. 
The Frist legislation had no provision 
that would postulate a federal govern-
ment program to petition the poor to sell 
their kidneys. Th e reasons for that con-
gressional opposition were not detailed 
in the report language associated with the 
legislation, but my personal conversation 
with congressional staff  brought forth a 
fundamental ethical principle: selling 
one’s kidney, selling a part of one’s liver, 
or selling any other part of one’s body vio-
lates the dignity of the human person. If 
this were not true, then Congress might 
be obliged to consider a parallel public 
policy that would permit its citizens to 
sell more than just their body parts. Th e 
key contention of the authors that one can 
dispose of one’s body as one sees fi t did 
not overcome what otherwise would have 
been a contentious battle of society before 
Congress to the contrary. Further, the 
notion that society’s acceptance of other 
high-risk activities is a basis to endorse 
kidney selling was not found by congres-
sional staff  to be realistic. Th ere are high-
risk activities, but military service or coal 
mining is not perceived as prostitution.
Notwithstanding the writings of Drs. 
Friedman and Friedman and others 
cited in their commentary, Congress is 
well aware that the current opposition to 
a regulated market of organ sales in the 
United States remains formidable. Th is 
opposition includes the National Kid-
ney Foundation, the American Society 
of Transplant Surgeons, and Th e Trans-
plantation Society (international). Th us, 
unless Congress were to be apprised of 
an overwhelming consensus of the public 
and the transplant community to change 
the current federal law, the authors may 
have to acknowledge that their arguments 
are not suffi  ciently compelling to do so. 
Th e 1984 National Organ Transplant Act 
that prohibits organ sales imposes the bur-
den on those who would change the law 
to muster the forces, but those concerted 
forces plainly do not exist.
The Friedmans have presented their 
thoughts not just from a United States per-
spective but to an international readership 
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via Kidney International. Th ere is indeed an 
international concern that the poor of sev-
eral countries are selling kidneys to affl  uent 
individuals who have the resources to make 
that purchase. Th ese sales are inherently 
coercive. What evidence do the authors 
have that enables the conclusion that the 
“sale of purchased donor kidneys [that] 
now accounts for thousands of black mar-
ket transplants” is “voluntary”?
The World Health Organization has 
recently conducted regional meetings in 
Manila and Karachi to obtain the insights 
of health officials about the transplant 
tourism that is occurring. Regional offi  -
cials agree that the black markets must 
be eliminated by a concerted eff ort of the 
United Nations, just as the black markets 
for the sale of women and children must 
be addressed.
Th e Friedmans seem out of touch when 
they suggest that “the number of deceased 
donor kidney transplants performed in the 
United States has been relatively static over 
the past decade.” As a result of the Organ 
Donation Collaborative, the United States 
is in the midst of unprecedented increases 
in the number of deceased organ donors.
Finally, the Friedmans pose this ques-
tion, seemingly the ultimate one for them: 
“What then is to be done to ease the short-
age of kidney donors?” Well, the authors 
might be just as fervent in recommend-
ing national policy that brings preventive 
medicine to improve public health. Obes-
ity, hypertension, adult-onset diabetes, and 
atherosclerotic disease are major compo-
nents of the increasing necessity for kidney 
transplants. Preventive medicine is omitted 
from the table of the authors’ solutions.
The “system failure” that the authors 
decry is not only at the doorstep of organ 
donation when the expansion of the wait-
ing list for kidney transplants is heav-
ily composed of the elderly whose poor 
medical care has resulted in end-stage 
renal disease.
Th e frequency with which patients die 
with a functioning graft  in the imme-
diate post-transplantation period may 
be refl ective of  the medical unsuitabil-
ity of some patients to undergo renal 
transplantation.6 If so, then perhaps the 
authors would consider that the true sys-
tem failure may be the expectation that 
the central solution resides in a limitless 
number of human organs. Unless and 
until an organ supply is derived from 
genetically manipulated pigs, some 
patients may die when the omission of 
preventive medical care has resulted in 
end-stage organ failure.
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Rewards for organ donation: the 
time has come
AP Monaco1
Strategies to expand the pool of solid organs for transplantation have 
had only limited success. Waiting times exceeding 5 years and/or 
waiting mortality are not uncommon. A system of financial rewards 
for living and deceased organ donation is proposed. The reward 
program would be  administered by the federal government. Donors 
or beneficiaries would receive a fixed financial reward, similar to the 
payout of an insurance policy, from a federal agency.  Such a system 
would be consistent with similar financial rewards given in our society to 
recognize instances of personal self-sacrifice and risk taking performed 
for the benefit of others.
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In their article “Payment for donor kid-
neys: Pros and cons,”1 in this issue (p 960), 
the very distinguished transplantation 
experts Eli and Amy Friedman present 
a thoughtful, well-organized, balanced 
analysis of the reasons to consider estab-
lishment of a “federal agency to manage 
the marketing and purchase of donor kid-
neys in collaboration with the United Net-
work for Organ Sharing.” I agree with the 
concepts and direction of their arguments 
to consider some type of compensation or 
fi nancial reward for organ donation. I do 
diff er in the details of how such a policy 
should be implemented. Also, I do not 
think that the function of such an agency 
should be described as the management 
of the marketing and purchase of donor 
kidneys — but more about that later.
Th e facts as presented are irrefutable: 
the number of people sustaining end-
stage renal failure annually continues to 
grow, the number of available kidneys 
(from living and deceased donors) that are 
successfully transplanted remains below 
the number required to keep up with this 
growth, and the time on the waiting list 
continues to increase (more than 5 years 
in many regions). A substantial number 
of people (7%) waiting on the list die each 
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